ClinicalTrials.gov
public full text
Public Domain
Oral Peanut Immunotherapy
Peanut allergy is one of the most serious food allergies because of its life long persistence, and the potential for severe allergic reactions. Effective oral immunotherapy would benefit patients by reducing the likelihood that they will have life-threatening accidental allergic reactions. This research study is being done to develop an effective oral immunotherapy treatment for patients with peanut allergy.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Efficacy and Safety of QGE031 (Ligelizumab) in Patients With Peanut Allergy#897207
- Efficacy and Safety of Belimumab in Primary Sjögren's Syndrome#1103084
- Effect of Intranasal Anti-IgE Antibodies on IgE Production#825752
- Allergic Rhinitis, Immunotherapy and Vitamin d#875721
- JWCAR201 for the Treatment of Hematology Malignancy and Autoimmune Diseases#1153440
Record · ID 907502
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive